Advances of berberine against metabolic syndrome-associated kidney disease: Regarding effect and mechanism
The prevalence of metabolic syndrome (MetS) is drastically growing worldwide, resulting in MetS-associated kidney disease. According to traditional theories, preventing blood pressure, lipid, glycose, and obesity and improving insulin resistance (IR), a couple of medications are required for MetS. I...
Main Authors: | Ya-Fei Liu, Huan-Huan Wang, Yin-Hong Geng, Liang Han, Sheng-Hao Tu, Hui Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1112088/full |
Similar Items
-
Effects of Berberine on the Gastrointestinal Microbiota
by: Lichao Zhang, et al.
Published: (2021-02-01) -
Pharmacokinetics and pharmacodynamics of HTD1801 (berberine ursodeoxycholate, BUDCA) in patients with hyperlipidemia
by: Adrian M. Di Bisceglie, et al.
Published: (2020-11-01) -
Integrated lipidomics and network pharmacology analysis to reveal the mechanisms of berberine in the treatment of hyperlipidemia
by: Yuting Chen, et al.
Published: (2022-09-01) -
The mechanism of berberine alleviating metabolic disorder based on gut microbiome
by: Han Wang, et al.
Published: (2022-08-01) -
Berberine in Non-Alcoholic Fatty Liver Disease—A Review
by: Anna Koperska, et al.
Published: (2022-08-01)